GlassScriptPhysician profile
Cynthia A Bates
NPI 1417332156
$552.97
in general payments reported to CMS, 2019-2025
12 companies · $67.80 in 2025
The $67.80 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.78 · 2022: $185 · 2023: $242 · 2025: $67.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $142.67 | 2022-2023 | Trelegy Ellipta |
| Abbvie INC. | $114.91 | 2022-2023 | |
| Hologic Sales and Service, LLC | $67.80 | 2025 | Acessa Provu System |
| Astrazeneca Pharmaceuticals LP | $46.19 | 2022-2023 | Farxiga |
| Novo Nordisk INC | $43.52 | 2023 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $30.68 | 2021-2022 | |
| Pfizer INC. | $30.50 | 2021 | |
| Amgen INC. | $19.01 | 2022 | |
| Exact Sciences Corporation | $15.25 | 2023 | Cologuard Collection Kit |
| Ultragenyx Pharmaceutical INC. | $15.02 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.29 | 2022 | |
| Organon LLC | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.